Other molecular defects (for example, modification in GNAS methylation) or defects in other mediators of PTH signaling in target tissues (for example, PRKAR1A) may also cause pseudohypoparathyroidism (A) (23). The gene discussed is PTH; the disease is pseudohypoparathyroidism.